{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:27:02Z","timestamp":1783488422928,"version":"3.55.0"},"reference-count":57,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2017,12,21]],"date-time":"2017-12-21T00:00:00Z","timestamp":1513814400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health (US)","doi-asserted-by":"crossref","award":["CTSA607 UL1 TR000448"],"award-info":[{"award-number":["CTSA607 UL1 TR000448"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health (US)","doi-asserted-by":"crossref","award":["CTSA607 UL1 TR000448"],"award-info":[{"award-number":["CTSA607 UL1 TR000448"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Staenberg and The Eberle family donation"},{"name":"The Staenberg and The Eberle family donation"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0190125","type":"journal-article","created":{"date-parts":[[2017,12,21]],"date-time":"2017-12-21T21:03:21Z","timestamp":1513890201000},"page":"e0190125","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["Adenovirus platform enhances transduction efficiency of human mesenchymal stem cells: An opportunity for cellular carriers of targeted TRAIL-based TR3 biologics in ovarian cancer"],"prefix":"10.1371","volume":"12","author":[{"given":"Lindsay M.","family":"Kuroki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingjian","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor P.","family":"Dmitriev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena A.","family":"Kashentseva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Mutch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan B.","family":"Dietz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T.","family":"Curiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William G.","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3949-1815","authenticated-orcid":true,"given":"Dirk","family":"Spitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,12,21]]},"reference":[{"key":"ref1","unstructured":"Howlader N NA, Krapcho M, Miller D, Bishop K, Altekruse SF, Kosary CL, et al. SEER Cancer Statistics Review, 1975\u20132013, National Cancer Institute. Bethesda, MD, <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/seer.cancer.gov\/csr\/1975_2013\/\" xlink:type=\"simple\">http:\/\/seer.cancer.gov\/csr\/1975_2013\/<\/ext-link>, based on November 2015 SEER data submission, posted to the SEER web site, April 2016. 2016."},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics, 2016","volume":"66","author":"RL Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/sj.cdd.4401187","article-title":"Apo2L\/TRAIL and its death and decoy receptors","volume":"10","author":"HN LeBlanc","year":"2003","journal-title":"Cell Death Differ"},{"issue":"22","key":"ref4","doi-asserted-by":"crossref","first-page":"12687","DOI":"10.1074\/jbc.271.22.12687","article-title":"Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family","volume":"271","author":"RM Pitti","year":"1996","journal-title":"J Biol Chem"},{"issue":"6","key":"ref5","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/1074-7613(95)90057-8","article-title":"Identification and characterization of a new member of the TNF family that induces apoptosis","volume":"3","author":"SR Wiley","year":"1995","journal-title":"Immunity"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"332","DOI":"10.4081\/oncol.2017.332","article-title":"Journey of TRAIL from Bench to Bedside and its Potential Role in Immuno-Oncology","volume":"11","author":"GE Naoum","year":"2017","journal-title":"Oncol Rev"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"660","DOI":"10.3332\/ecancer.2016.660","article-title":"Role of nanotechnology and gene delivery systems in TRAIL-based therapies","volume":"10","author":"GE Naoum","year":"2016","journal-title":"Ecancermedicalscience"},{"issue":"6","key":"ref8","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nrc.2017.28","article-title":"Exploring the TRAILs less travelled: TRAIL in cancer biology and therapy","volume":"17","author":"S von Karstedt","year":"2017","journal-title":"Nat Rev Cancer"},{"issue":"32","key":"ref9","doi-asserted-by":"crossref","first-page":"20121","DOI":"10.1074\/jbc.273.32.20121","article-title":"Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytes","volume":"273","author":"JM Escola","year":"1998","journal-title":"J Biol Chem"},{"issue":"4","key":"ref10","doi-asserted-by":"crossref","first-page":"RC209","DOI":"10.1523\/JNEUROSCI.22-04-j0001.2002","article-title":"Lack of tumor necrosis factor-related apoptosis-inducing ligand but presence of its receptors in the human brain","volume":"22","author":"J Dorr","year":"2002","journal-title":"J Neurosci"},{"issue":"5","key":"ref11","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/75045","article-title":"Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand","volume":"6","author":"M Jo","year":"2000","journal-title":"Nat Med"},{"issue":"8","key":"ref12","first-page":"3330","article-title":"Antitumor activity and bystander effects of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene","volume":"61","author":"S Kagawa","year":"2001","journal-title":"Cancer Res"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2174\/156652309787354612","article-title":"TRAIL gene therapy: from preclinical development to clinical application","volume":"9","author":"TS Griffith","year":"2009","journal-title":"Curr Gene Ther"},{"issue":"7","key":"ref14","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1158\/1535-7163.MCT-10-0225","article-title":"A genetically encoded multifunctional TRAIL trimer facilitates cell-specific targeting and tumor cell killing","volume":"9","author":"D Spitzer","year":"2010","journal-title":"Molecular cancer therapeutics"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1476-4598-5-50","article-title":"Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors","volume":"5","author":"JA Gubbels","year":"2006","journal-title":"Mol Cancer"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1471-2407-14-35","article-title":"Novel treatment option for MUC16-positive malignancies with the targeted TRAIL-based fusion protein Meso-TR3","volume":"14","author":"G Garg","year":"2014","journal-title":"BMC cancer"},{"key":"ref17","article-title":"Mesothelin&apos;s minimal MUC16 binding moiety converts TR3 into a potent cancer therapeutic via hierarchical binding events at the plasma membrane","author":"Y Su","year":"2016","journal-title":"Oncotarget"},{"issue":"8","key":"ref18","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1158\/0008-5472.CAN-04-2756","article-title":"Target cell-restricted apoptosis induction of acute leukemic T cells by a recombinant tumor necrosis factor-related apoptosis-inducing ligand fusion protein with specificity for human CD7","volume":"65","author":"E Bremer","year":"2005","journal-title":"Cancer Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"22661","DOI":"10.1038\/srep22661","article-title":"Membrane-proximal TRAIL species are incapable of inducing short circuit apoptosis signaling: Implications for drug development and basic cytokine biology","volume":"6","author":"K Tatzel","year":"2016","journal-title":"Sci Rep"},{"issue":"6","key":"ref20","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/stem.645","article-title":"Concise review: Mesenchymal stem cell tumor-homing: detection methods in disease model systems","volume":"29","author":"MR Reagan","year":"2011","journal-title":"Stem Cells"},{"issue":"10","key":"ref21","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1158\/0008-5472.CAN-08-4698","article-title":"Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancer","volume":"69","author":"MR Loebinger","year":"2009","journal-title":"Cancer Res"},{"issue":"11","key":"ref22","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1038\/sj.bjc.6605952","article-title":"TRAIL-expressing mesenchymal stem cells kill the putative cancer stem cell population","volume":"103","author":"MR Loebinger","year":"2010","journal-title":"Br J Cancer"},{"issue":"7","key":"ref23","first-page":"2953","article-title":"Fiber knob modifications overcome low, heterogeneous expression of the coxsackievirus-adenovirus receptor that limits adenovirus gene transfer and oncolysis for human rhabdomyosarcoma cells","volume":"61","author":"TP Cripe","year":"2001","journal-title":"Cancer Res"},{"issue":"16","key":"ref24","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1089\/hum.1998.9.16-2363","article-title":"The presence of human coxsackievirus and adenovirus receptor is associated with efficient adenovirus-mediated transgene expression in human melanoma cell cultures","volume":"9","author":"S Hemmi","year":"1998","journal-title":"Hum Gene Ther"},{"issue":"11","key":"ref25","first-page":"4323","article-title":"Selectivity of TAG-72-targeted adenovirus gene transfer to primary ovarian carcinoma cells versus autologous mesothelial cells in vitro","volume":"6","author":"FJ Kelly","year":"2000","journal-title":"Clin Cancer Res"},{"issue":"2","key":"ref26","first-page":"325","article-title":"Loss of adenoviral receptor expression in human bladder cancer cells: a potential impact on the efficacy of gene therapy","volume":"59","author":"Y Li","year":"1999","journal-title":"Cancer Res"},{"issue":"24","key":"ref27","first-page":"5738","article-title":"Differential susceptibility of primary and established human glioma cells to adenovirus infection: targeting via the epidermal growth factor receptor achieves fiber receptor-independent gene transfer","volume":"58","author":"CR Miller","year":"1998","journal-title":"Cancer Res"},{"issue":"5304","key":"ref28","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1126\/science.275.5304.1320","article-title":"Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5","volume":"275","author":"JM Bergelson","year":"1997","journal-title":"Science"},{"issue":"6","key":"ref29","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1128\/JVI.68.6.4104-4106.1994","article-title":"Cell-binding domain of adenovirus serotype 2 fiber","volume":"68","author":"N Louis","year":"1994","journal-title":"J Virol"},{"issue":"1","key":"ref30","first-page":"275","article-title":"Targeting adenovirus to the serotype 3 receptor increases gene transfer efficiency to ovarian cancer cells","volume":"8","author":"A Kanerva","year":"2002","journal-title":"Clin Cancer Res"},{"issue":"4","key":"ref31","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1634\/stemcells.21-4-389","article-title":"Approaches to utilize mesenchymal progenitor cells as cellular vehicles","volume":"21","author":"L Pereboeva","year":"2003","journal-title":"Stem Cells"},{"issue":"6","key":"ref32","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3727\/096368910X543376","article-title":"Platelet lysate consisting of a natural repair proteome supports human mesenchymal stem cell proliferation and chromosomal stability","volume":"20","author":"R Crespo-Diaz","year":"2011","journal-title":"Cell Transplant"},{"issue":"5382","key":"ref33","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1126\/science.281.5382.1509","article-title":"Identification of c-MYC as a target of the APC pathway","volume":"281","author":"TC He","year":"1998","journal-title":"Science"},{"issue":"2","key":"ref34","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1089\/hum.1996.7.2-215","article-title":"Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors","volume":"7","author":"FJ Fallaux","year":"1996","journal-title":"Human gene therapy"},{"issue":"1","key":"ref35","first-page":"115","article-title":"The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12","volume":"36","author":"JV Maizel Jr.","year":"1968","journal-title":"Virology"},{"issue":"1","key":"ref36","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/01.TP.0000066361.02042.CA","article-title":"Double genetic modification of adenovirus fiber with RGD polylysine motifs significantly enhances gene transfer to isolated human pancreatic islets","volume":"76","author":"JL Contreras","year":"2003","journal-title":"Transplantation"},{"issue":"13","key":"ref37","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1089\/10430340260201734","article-title":"Double modification of adenovirus fiber with RGD and polylysine motifs improves coxsackievirus-adenovirus receptor-independent gene transfer efficiency","volume":"13","author":"H Wu","year":"2002","journal-title":"Hum Gene Ther"},{"issue":"10","key":"ref38","doi-asserted-by":"crossref","first-page":"6839","DOI":"10.1128\/JVI.70.10.6839-6846.1996","article-title":"Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism","volume":"70","author":"VN Krasnykh","year":"1996","journal-title":"J Virol"},{"issue":"2","key":"ref39","doi-asserted-by":"crossref","first-page":"e55533","DOI":"10.1371\/journal.pone.0055533","article-title":"An adenovirus vector incorporating carbohydrate binding domains utilizes glycans for gene transfer","volume":"8","author":"JW Kim","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"ref40","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0378-1119(94)90186-4","article-title":"A multifunctional vector family for gene expression in mammalian cells","volume":"149","author":"W Dirks","year":"1994","journal-title":"Gene"},{"issue":"13","key":"ref41","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.molimm.2003.10.017","article-title":"ScFv-mediated in vivo targeting of DAF to erythrocytes inhibits lysis by complement","volume":"40","author":"D Spitzer","year":"2004","journal-title":"Molecular immunology"},{"issue":"Suppl 2","key":"ref42","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2174\/1874325001105010253","article-title":"Adult mesenchymal stem cells and cell surface characterization\u2014a systematic review of the literature","volume":"5","author":"P Mafi","year":"2011","journal-title":"Open Orthop J"},{"issue":"12","key":"ref43","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1176\/ajp.123.12.1553","article-title":"Comparison of psychiatric symptoms in carcinoma of the pancreas with those in some other intra-abdominal neoplasms","volume":"123","author":"I Fras","year":"1967","journal-title":"Am J Psychiatry"},{"issue":"18","key":"ref44","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1056\/NEJMra1407390","article-title":"Applying synthetic lethality for the selective targeting of cancer","volume":"371","author":"DP McLornan","year":"2014","journal-title":"N Engl J Med"},{"issue":"6B","key":"ref45","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1111\/j.1582-4934.2008.00317.x","article-title":"Mesenchymal stem cells expressing TRAIL lead to tumour growth inhibition in an experimental lung cancer model","volume":"12","author":"A Mohr","year":"2008","journal-title":"J Cell Mol Med"},{"issue":"9","key":"ref46","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/cgt.2012.46","article-title":"TRAIL-engineered pancreas-derived mesenchymal stem cells: characterization and cytotoxic effects on pancreatic cancer cells","volume":"19","author":"MR Moniri","year":"2012","journal-title":"Cancer Gene Ther"},{"issue":"4","key":"ref47","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/sj.gt.3302658","article-title":"Cancer gene therapy using a novel secretable trimeric TRAIL","volume":"13","author":"CY Kim","year":"2006","journal-title":"Gene Ther"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"e503","DOI":"10.1038\/cddis.2013.19","article-title":"Delivery of sTRAIL variants by MSCs in combination with cytotoxic drug treatment leads to p53-independent enhanced antitumor effects","volume":"4","author":"R Yu","year":"2013","journal-title":"Cell Death Dis"},{"issue":"9","key":"ref49","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1111\/j.1582-4934.2009.00794.x","article-title":"Growth inhibition of colorectal carcinoma by lentiviral TRAIL-transgenic human mesenchymal stem cells requires their substantial intratumoral presence","volume":"14","author":"J Luetzkendorf","year":"2010","journal-title":"J Cell Mol Med"},{"issue":"7","key":"ref50","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1136\/thoraxjnl-2013-204110","article-title":"Systemic but not topical TRAIL-expressing mesenchymal stem cells reduce tumour growth in malignant mesothelioma","volume":"69","author":"EK Sage","year":"2014","journal-title":"Thorax"},{"issue":"12","key":"ref51","doi-asserted-by":"crossref","first-page":"4822","DOI":"10.1073\/pnas.0806647106","article-title":"Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy","volume":"106","author":"LS Sasportas","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"ref52","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4048\/jbc.2012.15.3.273","article-title":"Stem Cell Implants for Cancer Therapy: TRAIL-Expressing Mesenchymal Stem Cells Target Cancer Cells In Situ","volume":"15","author":"MR Reagan","year":"2012","journal-title":"J Breast Cancer"},{"issue":"8","key":"ref53","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/gt.2010.58","article-title":"Branched oligomerization of cell-permeable peptides markedly enhances the transduction efficiency of adenovirus into mesenchymal stem cells","volume":"17","author":"SH Park","year":"2010","journal-title":"Gene Ther"},{"issue":"23","key":"ref54","doi-asserted-by":"crossref","first-page":"9614","DOI":"10.1158\/0008-5472.CAN-08-0451","article-title":"Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma","volume":"68","author":"SM Kim","year":"2008","journal-title":"Cancer Res"},{"issue":"9","key":"ref55","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1002\/stem.136","article-title":"Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy","volume":"27","author":"LG Menon","year":"2009","journal-title":"Stem Cells"},{"issue":"1","key":"ref56","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/neuonc\/noq147","article-title":"Therapeutic efficacy and safety of TRAIL-producing human adipose tissue-derived mesenchymal stem cells against experimental brainstem glioma","volume":"13","author":"SA Choi","year":"2011","journal-title":"Neuro Oncol"},{"issue":"2","key":"ref57","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1158\/1078-0432.CCR-12-1568","article-title":"Complete regression of metastatic renal cell carcinoma by multiple injections of engineered mesenchymal stem cells expressing dodecameric TRAIL and HSV-TK","volume":"19","author":"SW Kim","year":"2013","journal-title":"Clin Cancer Res"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0190125","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T18:06:10Z","timestamp":1603562770000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0190125"}},"subtitle":[],"editor":[{"given":"Joshua M.","family":"Hare","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,12,21]]},"references-count":57,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2017,12,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0190125","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,21]]}}}